QQQ   366.48 (-1.10%)
AAPL   166.23 (-2.10%)
MSFT   303.33 (+0.22%)
FB   319.59 (+0.45%)
GOOGL   2,702.33 (-0.65%)
AMZN   3,125.98 (-1.65%)
TSLA   995.65 (-3.38%)
NVDA   250.67 (-3.23%)
BABA   127.74 (-0.67%)
NIO   28.63 (-3.31%)
AMD   128.27 (-2.77%)
CGC   7.64 (-1.80%)
MU   90.00 (-3.09%)
GE   100.62 (-2.21%)
T   27.28 (-0.11%)
F   22.45 (-7.92%)
DIS   150.11 (-1.42%)
AMC   18.32 (-2.76%)
PFE   53.54 (-1.05%)
ACB   4.86 (-4.89%)
BA   217.08 (-3.52%)
QQQ   366.48 (-1.10%)
AAPL   166.23 (-2.10%)
MSFT   303.33 (+0.22%)
FB   319.59 (+0.45%)
GOOGL   2,702.33 (-0.65%)
AMZN   3,125.98 (-1.65%)
TSLA   995.65 (-3.38%)
NVDA   250.67 (-3.23%)
BABA   127.74 (-0.67%)
NIO   28.63 (-3.31%)
AMD   128.27 (-2.77%)
CGC   7.64 (-1.80%)
MU   90.00 (-3.09%)
GE   100.62 (-2.21%)
T   27.28 (-0.11%)
F   22.45 (-7.92%)
DIS   150.11 (-1.42%)
AMC   18.32 (-2.76%)
PFE   53.54 (-1.05%)
ACB   4.86 (-4.89%)
BA   217.08 (-3.52%)
QQQ   366.48 (-1.10%)
AAPL   166.23 (-2.10%)
MSFT   303.33 (+0.22%)
FB   319.59 (+0.45%)
GOOGL   2,702.33 (-0.65%)
AMZN   3,125.98 (-1.65%)
TSLA   995.65 (-3.38%)
NVDA   250.67 (-3.23%)
BABA   127.74 (-0.67%)
NIO   28.63 (-3.31%)
AMD   128.27 (-2.77%)
CGC   7.64 (-1.80%)
MU   90.00 (-3.09%)
GE   100.62 (-2.21%)
T   27.28 (-0.11%)
F   22.45 (-7.92%)
DIS   150.11 (-1.42%)
AMC   18.32 (-2.76%)
PFE   53.54 (-1.05%)
ACB   4.86 (-4.89%)
BA   217.08 (-3.52%)
QQQ   366.48 (-1.10%)
AAPL   166.23 (-2.10%)
MSFT   303.33 (+0.22%)
FB   319.59 (+0.45%)
GOOGL   2,702.33 (-0.65%)
AMZN   3,125.98 (-1.65%)
TSLA   995.65 (-3.38%)
NVDA   250.67 (-3.23%)
BABA   127.74 (-0.67%)
NIO   28.63 (-3.31%)
AMD   128.27 (-2.77%)
CGC   7.64 (-1.80%)
MU   90.00 (-3.09%)
GE   100.62 (-2.21%)
T   27.28 (-0.11%)
F   22.45 (-7.92%)
DIS   150.11 (-1.42%)
AMC   18.32 (-2.76%)
PFE   53.54 (-1.05%)
ACB   4.86 (-4.89%)
BA   217.08 (-3.52%)
NYSE:NUS

Nu Skin Enterprises Stock Forecast, Price & News

$52.01
-0.82 (-1.55%)
(As of 01/19/2022 04:00 PM ET)
Add
Compare
Today's Range
$51.92
$53.42
50-Day Range
$43.12
$54.26
52-Week Range
$39.40
$63.85
Volume
677,586 shs
Average Volume
550,607 shs
Market Capitalization
$2.59 billion
P/E Ratio
11.74
Dividend Yield
2.88%
Beta
1.24
30 days | 90 days | 365 days | Advanced Chart
Receive NUS News and Ratings via Email

Sign-up to receive the latest news and ratings for Nu Skin Enterprises and its competitors with MarketBeat's FREE daily newsletter.


Nu Skin Enterprises logo

About Nu Skin Enterprises

Nu Skin Enterprises, Inc. develops and distributes personal care products and nutritional supplements. The firm engages in the provision of beauty and wellness products and solutions. Its brands include Nu Skin and Pharmanex. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Drugs, proprietaries, & sundries
Sub-Industry
Personal Products
CUSIP
67018T10
Employees
5,000
Year Founded
N/A

Sales & Book Value

Annual Sales
$2.58 billion
Cash Flow
$5.00 per share
Book Value
$17.57 per share

Profitability

Net Income
$191.35 million
Pretax Margin
11.03%

Debt

Price-To-Earnings

Miscellaneous

Free Float
47,830,000
Market Cap
$2.59 billion
Optionable
Optionable

Company Calendar

Last Earnings
11/03/2021
Ex-Dividend for 12/8 Dividend
11/24/2021
Dividend Payable
12/08/2021
Today
1/19/2022
Next Earnings (Estimated)
2/09/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

2.86 out of 5 stars

Consumer Staples Sector

17th out of 184 stocks

Drugs, Proprietaries, & Sundries Industry

3rd out of 7 stocks

Analyst Opinion: 2.2Community Rank: 4.4Dividend Strength: 4.2Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -












Nu Skin Enterprises (NYSE:NUS) Frequently Asked Questions

Is Nu Skin Enterprises a buy right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last twelve months. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Nu Skin Enterprises stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NUS, but not buy additional shares or sell existing shares.
View analyst ratings for Nu Skin Enterprises
or view top-rated stocks.

How has Nu Skin Enterprises' stock price been impacted by COVID-19?

Nu Skin Enterprises' stock was trading at $21.06 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, NUS shares have increased by 147.0% and is now trading at $52.01.
View which stocks have been most impacted by COVID-19
.

When is Nu Skin Enterprises' next earnings date?

Nu Skin Enterprises is scheduled to release its next quarterly earnings announcement on Wednesday, February 9th 2022.
View our earnings forecast for Nu Skin Enterprises
.

How were Nu Skin Enterprises' earnings last quarter?

Nu Skin Enterprises, Inc. (NYSE:NUS) issued its quarterly earnings data on Wednesday, November, 3rd. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.86 by $0.11. The firm had revenue of $641.15 million for the quarter, compared to analyst estimates of $639.19 million. Nu Skin Enterprises had a net margin of 8.30% and a trailing twelve-month return on equity of 25.41%. During the same quarter in the prior year, the firm posted $1.08 earnings per share.
View Nu Skin Enterprises' earnings history
.

How often does Nu Skin Enterprises pay dividends? What is the dividend yield for Nu Skin Enterprises?

Nu Skin Enterprises announced a quarterly dividend on Wednesday, November 3rd. Stockholders of record on Friday, November 26th will be given a dividend of $0.38 per share on Wednesday, December 8th. This represents a $1.52 annualized dividend and a yield of 2.92%. The ex-dividend date of this dividend is Wednesday, November 24th.
View Nu Skin Enterprises' dividend history
.

Is Nu Skin Enterprises a good dividend stock?

Nu Skin Enterprises pays an annual dividend of $1.52 per share and currently has a dividend yield of 2.88%. Nu Skin Enterprises has been increasing its dividend for 22 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Nu Skin Enterprises is 34.31%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Nu Skin Enterprises will have a dividend payout ratio of 36.28% next year. This indicates that Nu Skin Enterprises will be able to sustain or increase its dividend.
View Nu Skin Enterprises' dividend history.

What guidance has Nu Skin Enterprises issued on next quarter's earnings?

Nu Skin Enterprises issued an update on its FY 2021 earnings guidance on Wednesday, November, 17th. The company provided EPS guidance of $3.930-$4.030 for the period, compared to the Thomson Reuters consensus estimate of $3.880. The company issued revenue guidance of $2.67 billion-$2.70 billion, compared to the consensus revenue estimate of $2.66 billion.

What price target have analysts set for NUS?

5 brokerages have issued 1 year target prices for Nu Skin Enterprises' shares. Their forecasts range from $47.00 to $72.00. On average, they expect Nu Skin Enterprises' stock price to reach $59.60 in the next year. This suggests a possible upside of 14.6% from the stock's current price.
View analysts' price targets for Nu Skin Enterprises
or view top-rated stocks among Wall Street analysts.

Who are Nu Skin Enterprises' key executives?

Nu Skin Enterprises' management team includes the following people:
  • Ryan S. Napierski, President, Chief Executive Officer & Director
  • Mark H. Lawrence, Chief Financial Officer & Executive Vice President
  • Joseph Y. Chang, Chief Scientific Officer & EVP-Product Development (LinkedIn Profile)
  • Helen E. Knaggs, Vice President-Global Research & Development
  • Vince Perfetti, Chief Transformation Officer & SVP-Technology

What is Ritch Wood's approval rating as Nu Skin Enterprises' CEO?

72 employees have rated Nu Skin Enterprises CEO Ritch Wood on Glassdoor.com. Ritch Wood has an approval rating of 91% among Nu Skin Enterprises' employees. This puts Ritch Wood in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Nu Skin Enterprises own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nu Skin Enterprises investors own include Alibaba Group (BABA), General Electric (GE), NVIDIA (NVDA), Marathon Petroleum (MPC), Gilead Sciences (GILD), Alphabet (GOOG), Tesla (TSLA), Herbalife Nutrition (HLF), Mastercard (MA) and Netflix (NFLX).

What is Nu Skin Enterprises' stock symbol?

Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."

Who are Nu Skin Enterprises' major shareholders?

Nu Skin Enterprises' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Exchange Traded Concepts LLC (0.02%), State of Alaska Department of Revenue (0.01%) and Crossmark Global Holdings Inc. (0.01%). Company insiders that own Nu Skin Enterprises stock include D Matthew Dorny, James D Thomas, Jeffrey Clark Bettinger, Joseph Y Chang, Mark H Lawrence, Ritch N Wood, Ryan S Napierski and Steven Lund.
View institutional ownership trends for Nu Skin Enterprises
.

Which institutional investors are selling Nu Skin Enterprises stock?

NUS stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue. Company insiders that have sold Nu Skin Enterprises company stock in the last year include D Matthew Dorny, James D Thomas, Jeffrey Clark Bettinger, Joseph Y Chang, Mark H Lawrence, Ritch N Wood, and Ryan S Napierski.
View insider buying and selling activity for Nu Skin Enterprises
or view top insider-selling stocks.

Which institutional investors are buying Nu Skin Enterprises stock?

NUS stock was purchased by a variety of institutional investors in the last quarter, including Crossmark Global Holdings Inc., and Exchange Traded Concepts LLC. Company insiders that have bought Nu Skin Enterprises stock in the last two years include Ritch N Wood, and Steven Lund.
View insider buying and selling activity for Nu Skin Enterprises
or or view top insider-buying stocks.

How do I buy shares of Nu Skin Enterprises?

Shares of NUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Nu Skin Enterprises' stock price today?

One share of NUS stock can currently be purchased for approximately $52.01.

How much money does Nu Skin Enterprises make?

Nu Skin Enterprises has a market capitalization of $2.59 billion and generates $2.58 billion in revenue each year. The company earns $191.35 million in net income (profit) each year or $4.43 on an earnings per share basis.

How many employees does Nu Skin Enterprises have?

Nu Skin Enterprises employs 5,000 workers across the globe.

What is Nu Skin Enterprises' official website?

The official website for Nu Skin Enterprises is www.nuskinenterprises.com.

Where are Nu Skin Enterprises' headquarters?

Nu Skin Enterprises is headquartered at 75 WEST CENTER ST, PROVO UT, 84601.

How can I contact Nu Skin Enterprises?

Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The company can be reached via phone at (801) 345-1000, via email at [email protected], or via fax at 801-345-5999.


This page was last updated on 1/19/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.